207 related articles for article (PubMed ID: 22176671)
21. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.
Hegarty NJ; Gill IS; Desai MM; Remer EM; O'Malley CM; Kaouk JH
Urology; 2006 Jul; 68(1 Suppl):7-13. PubMed ID: 16857454
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation of large renal angiomyolipoma: median-term follow-up.
Gregory SM; Anderson CJ; Patel U
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):682-9. PubMed ID: 23354958
[TBL] [Abstract][Full Text] [Related]
23. [Clinical evaluation of renal angiomyolipoma].
Takehara K; Koga S; Nishikido M; Tsurusaki T; Eguchi J; Matsuya F; Kanetake H; Hayashi T
Hinyokika Kiyo; 2001 Oct; 47(10):705-8. PubMed ID: 11758350
[TBL] [Abstract][Full Text] [Related]
24. Is radiofrequency ablation safe for solitary kidneys?
Jacobsohn KM; Ahrar K; Wood CG; Matin SF
Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic cryoablation of renal angiomyolipoma.
Byrd GF; Lawatsch EJ; Mesrobian HG; Begun F; Langenstroer P
J Urol; 2006 Oct; 176(4 Pt 1):1512-6; discussion 1516. PubMed ID: 16952669
[TBL] [Abstract][Full Text] [Related]
27. Progression of renal tumors after laparoscopic radiofrequency ablation.
Uribe PS; Costabile RA; Peterson AC
Urology; 2006 Nov; 68(5):968-71. PubMed ID: 17095053
[TBL] [Abstract][Full Text] [Related]
28. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
29. Laparoscopic nephron-sparing surgery in the management of angiomyolipoma: a single center experience.
Msezane L; Chang A; Shikanov S; Deklaj T; Katz MH; Shalhav AL; Lifshitz DA
J Endourol; 2010 Apr; 24(4):583-7. PubMed ID: 20423289
[TBL] [Abstract][Full Text] [Related]
30. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
[TBL] [Abstract][Full Text] [Related]
31. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
Raman JD; Raj GV; Lucas SM; Williams SK; Lauer EM; Ahrar K; Matin SF; Leveillee RJ; Cadeddu JA
BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation for renal tumors: our experience.
Hiraoka K; Kawauchi A; Nakamura T; Soh J; Mikami K; Miki T
Int J Urol; 2009 Nov; 16(11):869-73. PubMed ID: 19735313
[TBL] [Abstract][Full Text] [Related]
33. Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications.
Seideman CA; Gahan J; Weaver M; Olweny EO; Richter M; Chan D; Cadeddu JA
BJU Int; 2013 Dec; 112(8):1121-4. PubMed ID: 24053576
[TBL] [Abstract][Full Text] [Related]
34. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation--incidence and clinical importance in 101 consecutive patients.
Schirmang TC; Mayo-Smith WW; Dupuy DE; Beland MD; Grand DJ
Radiology; 2009 Oct; 253(1):263-9. PubMed ID: 19703853
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
36. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
[TBL] [Abstract][Full Text] [Related]
37. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
38. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens.
Park S; Strup SE; Saboorian H; Cadeddu JA
Urology; 2006 Nov; 68(5):964-7. PubMed ID: 17113888
[TBL] [Abstract][Full Text] [Related]
39. Imaging-guided radiofrequency ablation of cystic renal neoplasms.
Allen BC; Chen MY; Childs DD; Zagoria RJ
AJR Am J Roentgenol; 2013 Jun; 200(6):1365-9. PubMed ID: 23701077
[TBL] [Abstract][Full Text] [Related]
40. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience.
Nitta Y; Tanaka T; Morimoto K; Makino T; Nishikawa N; Tashiro K; Naganuma T; Iguchi T; Matsuoka T; Nakatani T
Anticancer Res; 2012 Feb; 32(2):615-8. PubMed ID: 22287753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
